| Candidalysin is a fungal peptide toxin critical for mucosal infection DL Moyes, D Wilson, JP Richardson, S Mogavero, SX Tang, J Wernecke, ... Nature 532 (7597), 64-68, 2016 | 913 | 2016 |
| Candida albicans proteinases and host/pathogen interactions J Naglik, A Albrecht, O Bader, B Hube Cellular microbiology 6 (10), 915-926, 2004 | 462 | 2004 |
| Adhesins in human fungal pathogens: glue with plenty of stick PWJ de Groot, O Bader, AD de Boer, M Weig, N Chauhan Eukaryotic cell 12 (4), 470-481, 2013 | 381 | 2013 |
| Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence S Ferrari, F Ischer, D Calabrese, B Posteraro, M Sanguinetti, G Fadda, ... PLoS pathogens 5 (1), e1000268, 2009 | 340 | 2009 |
| The Cell Wall of the Human Pathogen Candida glabrata: Differential Incorporation of Novel Adhesin-Like Wall Proteins PWJ de Groot, EA Kraneveld, QY Yin, HL Dekker, U Groß, W Crielaard, ... Eukaryotic cell 7 (11), 1951-1964, 2008 | 305 | 2008 |
| Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry O Bader, M Weig, L Taverne-Ghadwal, R Lugert, U Gross, M Kuhns Clinical Microbiology and Infection 17 (9), 1359-1365, 2011 | 294 | 2011 |
| Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans CM Martel, JE Parker, O Bader, M Weig, U Gross, AGS Warrilow, N Rolley, ... Antimicrobial agents and chemotherapy 54 (11), 4527-4533, 2010 | 210 | 2010 |
| A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to … CM Martel, JE Parker, O Bader, M Weig, U Gross, AGS Warrilow, DE Kelly, ... Antimicrobial agents and chemotherapy 54 (9), 3578-3583, 2010 | 196 | 2010 |
| MALDI‐TOF‐MS‐based species identification and typing approaches in medical mycology O Bader Proteomics 13 (5), 788-799, 2013 | 195 | 2013 |
| cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany O Bader, M Weig, U Reichard, R Lugert, M Kuhns, M Christner, J Held, ... Antimicrobial agents and chemotherapy 57 (8), 3513-3517, 2013 | 141 | 2013 |
| Remote near infrared identification of pathogens with multiplexed nanosensors R Nißler, O Bader, M Dohmen, SG Walter, C Noll, G Selvaggio, U Groß, ... Nature communications 11 (1), 5995, 2020 | 131 | 2020 |
| Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance … CM Hull, JE Parker, O Bader, M Weig, U Gross, AGS Warrilow, DE Kelly, ... Antimicrobial agents and chemotherapy 56 (8), 4223-4232, 2012 | 130 | 2012 |
| Rapid discrimination of Salmonella enterica serovar Typhi from other serovars by MALDI-TOF mass spectrometry M Kuhns, AE Zautner, W Rabsch, O Zimmermann, M Weig, O Bader, ... PLoS One 7 (6), e40004, 2012 | 120 | 2012 |
| Processing of predicted substrates of fungal Kex2 proteinases from Candida albicans, C. glabrata, Saccharomyces cerevisiae and Pichia pastoris O Bader, Y Krauke, B Hube BMC microbiology 8, 1-16, 2008 | 118 | 2008 |
| Patterns of genomic variation in the opportunistic pathogen Candida glabrata suggest the existence of mating and a secondary association with humans L Carreté, E Ksiezopolska, C Pegueroles, E Gómez-Molero, E Saus, ... Current Biology 28 (1), 15-27. e7, 2018 | 117 | 2018 |
| Environmental isolates of azole-resistant Aspergillus fumigatus in Germany O Bader, J Tünnermann, A Dudakova, M Tangwattanachuleeporn, ... Antimicrobial agents and chemotherapy 59 (7), 4356-4359, 2015 | 113 | 2015 |
| Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species A Dudakova, B Spiess, M Tangwattanachuleeporn, C Sasse, D Buchheidt, ... Clinical microbiology reviews 30 (4), 1065-1091, 2017 | 106 | 2017 |
| Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations in ERG2 CM Hull, O Bader, JE Parker, M Weig, U Gross, AGS Warrilow, DE Kelly, ... Antimicrobial agents and chemotherapy 56 (12), 6417-6421, 2012 | 103 | 2012 |
| CandidaDB: a genome database for Candida albicans pathogenomics C d'Enfert, S Goyard, S Rodriguez-Arnaveilhe, L Frangeul, L Jones, ... Nucleic Acids Research 33 (suppl_1), D353-D357, 2005 | 102 | 2005 |
| Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation R Mössner, N Diering, O Bader, S Forkel, T Overbeck, U Gross, ... Clinical Infectious Diseases 62 (7), 951-953, 2016 | 98 | 2016 |
